A vital CDC advisory group is reevaluating the timing of the hepatitis B vaccine for infants. Currently administered within hours of birth, the proposed change would delay the first dose until babies are at least one month old, reflecting a potential shift in public health policy.
Subscribe
Healthcare Reforms
Infectious Diseases
CDC Advisers to Consider Removing Hepatitis B Vaccine From Childhood Schedule
Photo by The Epoch Times
Key Takeaways:
- The CDC’s ACIP is considering revising the recommended hepatitis B vaccine schedule.
- The first dose may move from “hours after birth” to “at least one month.”
- The move represents a significant departure from existing policy.
- The Epoch Times reported these potential changes in September 2025.
Context
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) plays a key role in shaping vaccine schedules across the United States. According to newly released information, the ACIP is weighing a notable alteration to the early vaccination routine for infants, specifically regarding hepatitis B.
The Current Schedule
Under existing guidelines, most newborns receive their first hepatitis B vaccine dose shortly after birth—often within the first 24 hours of life. This longstanding approach aims to provide early protection against hepatitis B, a virus that can affect the liver and lead to chronic health issues.
Proposed Change
However, the ACIP “was to vote on changing the first dose recommendation from within hours of birth to a minimum of one month after birth.” This shift would mark a significant departure from the immediate post-birth timing, effectively postponing early vaccination in favor of administering it when infants are older.
Reaction and Next Steps
While specific conclusions or outcomes were not detailed in the brief feed information, the possibility of delaying the hepatitis B vaccine has prompted new discussions within public health circles. The ramifications of moving the dose later in infancy may include adjustments for pediatricians and hospitals, along with potential updates to federal guidelines if ultimately approved.
Conclusion
This development, outlined by journalist Zachary Stieber and published by The Epoch Times, underscores the ongoing evaluations of how best to protect newborns from hepatitis B. Should the ACIP vote in favor of the revision, it would become a significant change to a standard immunization practice that has been in place for decades.
